Maternal obesity programs offspring non-alcoholic fatty liver disease through disruption of 24-h rhythms in mice
Mouralidarane, A, Soeda, J, Sugden, D, Bocianowska, A, Carter, R, Ray, S, Saraswati, R, Cordero, P, Novelli, M, Fusai, G, Vinciguerra, M, Poston, L, Taylor, P D, Oben, J A
Published in International Journal of Obesity (01.09.2015)
Published in International Journal of Obesity (01.09.2015)
Get full text
Journal Article
Band-like transport in solution-crystallized organic transistors
Uemura, T., Nakayama, K., Hirose, Y., Soeda, J., Uno, M., Li, W., Yamagishi, M., Okada, Y., Takeya, J.
Published in Current applied physics (01.12.2012)
Published in Current applied physics (01.12.2012)
Get full text
Journal Article
PARADIGM study: A multicenter, randomized, phase III study of mFOLFOX6 plus panitumumab or bevacizumab as first-line treatment in patients with RAS (KRAS/NRAS) wild-type metastatic colorectal cancer
Muro, K., Uetake, H., Tsuchihara, K., Shitara, K., Yamazaki, K., Ota, M., Oki, E., Sato, T., Naitoh, T., Komatsu, Y., Kato, T., Yamanaka, K., Mori, I., Soeda, J., Hihara, M., Yamanaka, T., Akagi, K., Ochiai, A., Yoshino, T.
Published in Annals of oncology (01.07.2019)
Published in Annals of oncology (01.07.2019)
Get full text
Journal Article
A phase I/II study of panitumumab combined with TAS-102 in patients (pts) with RAS wild-type (wt) metastatic colorectal cancer (mCRC) refractory to standard chemotherapy: APOLLON study
Yamazaki, K., Yasui, H., Yamaguchi, K., Kagawa, Y., Kuboki, Y., Yoshino, T., Gamoh, M., Komatsu, Y., Satake, H., Goto, M., Tanioka, H., Oki, E., Kotaka, M., Makiyama, A., Denda, T., Soeda, J., Shibya, K., Iwata, M., Oba, K., Kato, T.
Published in Annals of oncology (01.06.2018)
Published in Annals of oncology (01.06.2018)
Get full text
Journal Article
P600 SYMPATHETIC NERVOUS SYSTEM SIGNALLING REGULATES HEPATIC FIBROGENESIS THROUGH MODULATION OF KUPFFER CELL REACTIVE OXYGEN SPECIES AND INFLAMMATORY CYTOKINES PRODUCTION
Soeda, J, Lin, C.-I, Fusai, G, Davidson, B, Oben, J.A
Published in Journal of hepatology (01.04.2014)
Published in Journal of hepatology (01.04.2014)
Get full text
Journal Article
O091 : Oral therapy with non-absorbable carbons of controlled porosity (YAQ-001) selectively modulates stool microbiome and its function and this is associated with restoration of immune function and inflammasome activation
Macnaughtan, J, Ranchal, I, Soeda, J, Sawhney, R, Oben, J, Davies, N, Mookerjee, R, Marchesi, J, Cox, J, Jalan, R
Published in Journal of hepatology (01.04.2015)
Published in Journal of hepatology (01.04.2015)
Get full text
Journal Article
OP06 Maternal obesity programs offspring innate immune dysregulation in non-alcoholic fatty liver disease
Mouralidarane, A, Soeda, J, Samuelsson, Anne-Maj, Taylor, P, Poston, L, Oben, J A
Published in Gut (01.09.2011)
Published in Gut (01.09.2011)
Get full text
Journal Article
PMO-128 Effects of oral nanoporous carbon therapy in leptin null mice as a model of non-alcoholic steatohepatitis
Macnaughtan, J, Soeda, J, Mouralidarane, A, Sandeman, S, Howell, C, Milkhalovsky, S, Kozynchenko, O, Tennison, S, Davies, N, Mookerjee, R, Oben, J, Jalan, R
Published in Gut (01.07.2012)
Published in Gut (01.07.2012)
Get full text
Journal Article
PMO-127 Biological effects of oral nanoporous carbon in bile duct ligated rats
Macnaughtan, J, Soeda, J, Mouralidarane, A, Sandeman, S, Howell, C, Kozynchenko, O, Tennison, S, Mikhalovsky, S, Davies, N, Oben, J, Mookerjee, R, Jalan, R
Published in Gut (01.07.2012)
Published in Gut (01.07.2012)
Get full text
Journal Article
581 GUT DECONTAMINATION USING NANOPOROUS CARBONS REDUCES PORTAL PRESSURE AND PREVENTS LIVER FAILURE IN BILE-DUCT LIGATED CIRRHOTIC ANIMALS BY REDUCING KUPFFER CELL ACTIVATION
Macnaughtan, J, Soeda, J, Mouralidarane, A, Sandeman, S, Howell, C, Mikhalovsky, S, Kozynchenko, S, Tennison, S, Davies, N, Oben, J, Mookerjee, R, Jalan, R
Published in Journal of hepatology (01.04.2012)
Published in Journal of hepatology (01.04.2012)
Get full text
Journal Article
1248 ORAL ADMINISTRATION OF NANOPOROUS CARBONS REDUCE SEVERITY OF NON-ALCOHOLIC STEATOHEPATITIS BY MODULATING HEPATIC KUPFFER CELL FUNCTION: A NOVEL THERAPEUTIC APPROACH
Macnaughtan, J, Soeda, J, Mouralidarane, A, Sandeman, S, Howell, C, Kozynchenko, S, Mikhalovsky, S, Tennison, S, Davies, N, Mookerjee, R, Oben, J, Jalan, R
Published in Journal of hepatology (01.04.2012)
Published in Journal of hepatology (01.04.2012)
Get full text
Journal Article
PB2019: EFFICACY AND SAFETY OF IXAZOMIB PLUS LENALIDOMIDE AND DEXAMETHASONE FOLLOWING INJECTABLE PROTEASOME INHIBITOR-BASED THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
Sasaki, M., Suzuki, K., Abe, Y., Ito, S., Nishiwaki, K., Handa, H., Chou, T., Soeda, J., Mori, I., Shinozaki, T., Takezako, N.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
Mac-1 (CD11b/CD18) and intercellular adhesion molecule-1 in ischemia-reperfusion injury of rat liver
Kobayashi, A, Imamura, H, Isobe, M, Matsuyama, Y, Soeda, J, Matsunaga, K, Kawasaki, S
Published in American journal of physiology: Gastrointestinal and liver physiology (01.08.2001)
Published in American journal of physiology: Gastrointestinal and liver physiology (01.08.2001)
Get full text
Journal Article
Staged hepatectomy after emergency transcatheter arterial embolization for ruptured hepatocellular carcinoma
Shimada, Ryo, Imamura, Hiroshi, Makuuchi, Masatoshi, Soeda, Junpei, Kobayashi, Akira, Noike, Terumasa, Miyagawa, Shin-ichi, Kawasaki, Seiji
Published in Surgery (01.09.1998)
Published in Surgery (01.09.1998)
Get full text
Journal Article
127P A meta-analysis of efficacy and safety from head-to-head first-line (1L) trials of epidermal growth factor receptor inhibitors (EGFRIs) versus bevacizumab in combination with chemotherapy (CT) doublets in patients with RAS wild-type (WT) metastatic colorectal cancer (mCRC) by sidedness
Yoshino, T., Hooda, N., Younan, D., Muro, K., Shitara, K., Heinemann, V., O’Neil, B., Rivera Herrero, F., Peeters, M., Soeda, J., Suh, M., Reichart, H., Mezzi, K., Fryzek, J., Chia, V., Rehn, M., Stintzing, S.
Published in Annals of oncology (01.11.2023)
Published in Annals of oncology (01.11.2023)
Get full text
Journal Article
90MO Panitumumab (PAN) vs bevacizumab (BEV) in metastatic colorectal cancer (mCRC) by microsatellite stable (MSS), RAS/BRAF, and HER2 amplification (HER2amp) status: Phase III PARADIGM biomarker study
Kato, T., Muro, K., Watanabe, J., Shitara, K., Yamazaki, K., Ohori, H., Shiozawa, M., Yasui, H., Oki, E., Sato, T., Naitoh, T., Komatsu, Y., Soeda, J., Yamamoto, K., Yamashita, R., Akagi, K., Ochiai, A., Uetake, H., Tsuchihara, K., Yoshino, T.
Published in Annals of oncology (01.11.2023)
Published in Annals of oncology (01.11.2023)
Get full text
Journal Article
MA14.01 Distribution and Detectability of EGFR Exon 20 Insertion Variants in Non–Small Cell Lung Cancer
Ou, S., Hong, J., Lin, H., Vincent, S., Churchill, E., Soeda, J., Christopoulos, P., Stenzinger, A., Thomas, M.
Published in Journal of thoracic oncology (01.10.2021)
Published in Journal of thoracic oncology (01.10.2021)
Get full text
Journal Article
388P Early tumor shrinkage (ETS) and depth of response (DpR) analyses in metastatic colorectal cancer (mCRC) treated with first-line mFOLFOX6 plus panitumumab (PAN) or bevacizumab (BEV): Results from the phase III PARADIGM trial
Muro, K., Watanabe, J., Shitara, K., Yamazaki, K., Ohori, H., Shiozawa, M., Yasui, H., Oki, E., Sato, T., Naitoh, T., Komatsu, Y., Kato, T., Hihara, M., Soeda, J., Yamamoto, K., Akagi, K., Ochiai, A., Uetake, H., Tsuchihara, K., Yoshino, T.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article